S&P 500 7,585.73 −0.45%
Nasdaq 25,981.57 −0.78%
S&P/TSX 35,582.07 −0.34%
Apple 331.34 −0.52%
Nvidia 212.17 +0.57%
Microsoft 497.12 −1.64%
Shopify 180.80 −2.89%
Royal Bank 284.21 −0.34%
CAD/USD 0.7179 −0.21%
CLOSED · 01:00 ET
Market ClerkRecap
Wed Sep 16 · markets closed4 signals on Sep 15287 insider buys this week · $349.4MCIRO short report next: Sep 29The week ahead

ISCO

International Stem Cell CORP
OTC · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
0.32
−0.06 −15.79%
USD · close Sep 15

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose ISCO in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on ISCO in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch ISCO. Know when insiders buy.
One email the day a filing lands. Free.